Vaccine Design and Development

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Attenuated/Inactivated/Live and Vectored Vaccines".

Deadline for manuscript submissions: 31 January 2026 | Viewed by 71

Special Issue Editor


E-Mail Website
Guest Editor
Institute of Clinical and Molecular Virology of the Universitätsklinikum Erlangen, Schlossgarten 4, 91054 Erlangen, Germany
Interests: B-cell targeting nanoparticle vaccines; HIV vaccines; vaccine adjuvants
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

I invite you to contribute to this Special Issue focused on "Vaccine Design and Development". Vaccines are a cornerstone of modern medicine, having a role in the prevention of infectious diseases. Despite the remarkable success of existing vaccines, significant challenges remain. These challenges include new pathogens, antimicrobial resistance, difficulties in developing vaccines for certain diseases, and improved vaccine efficacy, safety, and accessibility. Continued vaccine design and development innovation is essential for addressing these challenges and safeguarding global health. This Special Issue highlights this dynamic field's latest breakthroughs and innovative strategies.

This Special Issue will cover various topics, from basic antigen identification and immune response research to developing and evaluating novel vaccine platforms and technologies. Our goal is to focus on innovative approaches pushing the boundaries of vaccinology and contributing to creating more effective and accessible vaccines. Contributions in the form of original research articles and reviews are welcome.

Research areas may include:

  • Novel vaccine platforms, which include viral vectors, nucleic acid, protein-based, virus-like particles, and live attenuated vaccines.
  • Adjuvant discovery and formulation, which includes new adjuvants to enhance vaccine immunogenicity and durability.
  • Antigen design and optimization, which focuses on the identification and engineering of protective antigens.
  • Immunological correlates of protection, which investigates the immune responses elicited by vaccines and identifies correlates of protection.
  • Vaccine delivery systems, which focuses on developing innovative methods for vaccine delivery.
  • Preclinical and clinical evaluation of vaccines, which involves sharing data from preclinical studies and clinical trials, including safety and efficacy assessments.

I look forward to receiving your contributions.

Dr. Vladimir Temchura
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccine design
  • vaccine development
  • vaccinology
  • immunization
  • immune response
  • vaccine delivery
  • vaccine efficacy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop